Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $18.2900 (-1.72%) ($18.1800 - $19.2400) on Wed. Jul. 10, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.02% (three month average) | RSI | 25 | Latest Price | $18.2900(-1.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.7% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.01% in a week (0% probabilities). VIXM(-36%) VXX(-34%) TLT(-13%) UNG(-6%) IFRA(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.01% (StdDev 4.02%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
1 - 5 Day Possible Target | $7.84(-57.14%) | Resistance Level | $20.37 | 5 Day Moving Average | $19.02(-3.84%) | 10 Day Moving Average | $19.38(-5.62%) | 20 Day Moving Average | $20.37(-10.21%) | To recent high | -50.8% | To recent low | 0% | Market Cap | $1.359b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |